Amgen Inc

Ownership Transactions Reported by 25 Insiders

Symbol
AMGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Amgen Center Drive, Thousand Oaks, California

Insiders trading volume in the past year

Amgen Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert A. Bradway Chairman, CEO and President, Director $232M May 7, 2024
Esteban Santos EVP, Operations $33.4M May 7, 2024
Murdo Gordon EVP, Global Commercial Ops $30.2M -$2.51M -7.68% May 7, 2024
David M. Reese EVP & Chief Technology Officer $25.5M May 7, 2024
Peter H. Griffith Evp & Cfo $17.4M May 7, 2024
Jonathan P. Graham EVP & Gen. Counsel & Secy. $16.5M -$2.73M -14.2% May 7, 2024
James E. Bradner EVP, R&D, & Chief Sci. Officer $13.5M May 7, 2024
Lori A. Johnston Evp, Hr $11.2M Mar 1, 2022
Derek Miller SVP, Human Resources $6.17M May 7, 2024
Robert Eckert Director $6.13M May 19, 2023
Ronald D. Sugar Director $5.37M May 19, 2023
Nancy A. Grygiel Svp & Cco $4.21M -$1.24M -22.7% May 7, 2024
Tyler Jacks Director $4.06M May 19, 2023
Linda H. Louie VP, Finance & CAO $3.8M May 5, 2023
Rachna Khosla SVP, Business Development $3.7M May 7, 2024
Greg C. Garland Director $3.18M May 19, 2023
Charles M. Holley Director $3.15M May 7, 2024
Ellen Jamison Kullman Director $3.06M May 19, 2023
Matthew C. Busch VP, Finance & CAO $2.18M May 7, 2024
R. Sanders Williams Director $1.7M May 19, 2023
Wanda M. Austin Director $1.59M May 19, 2023
Brian Druker Director $1.55M May 19, 2023
Omar Ishrak Director $1.24M May 7, 2024
Amy E. Miles Director $850K May 19, 2023
Michael V. Drake Director $764K May 7, 2024

Recent Insider Transactions by Companies or Individuals for Amgen Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership